Smoking and its treatment in addiction services: Clients’ and staff behaviour and attitudes by Camilla Cookson et al.
Cookson et al. BMC Health Services Research 2014, 14:304
http://www.biomedcentral.com/1472-6963/14/304RESEARCH ARTICLE Open AccessSmoking and its treatment in addiction services:
Clients’ and staff behaviour and attitudes
Camilla Cookson1, John Strang1,4, Elena Ratschen2,3, Gay Sutherland1, Emily Finch4 and Ann McNeill1,3*Abstract
Background: High smoking prevalence has been observed among those misusing other substances. This study
aimed to establish smoking behaviours and attitudes towards nicotine dependence treatment among clients and
staff in substance abuse treatment settings.
Methods: Cross-sectional questionnaire survey of staff and clients in a convenience sample of seven community
and residential addiction services in, or with links to, Europe’s largest provider of mental health care, the South
London and Maudsley NHS Foundation Trust. Survey items assessed smoking behaviour, motivation to quit, receipt
of and attitudes towards nicotine dependence treatment.
Results: Eighty five percent (n = 163) and 97% (n = 145) response rates of clients and staff were achieved. A high
smoking prevalence was observed in clients (88%) and staff (45%); of current smokers, nearly all clients were daily
smokers, while 42% of staff were occasional smokers. Despite 79% of clients who smoked expressing a desire to
quit and 46% interested in receiving advice, only 15% had been offered support to stop smoking during their
current treatment episode with 56% reported never having been offered support. Staff rated smoking treatment
significantly less important than treatment of other substances (p < 0.001), and only 29% of staff thought it should
be addressed early in a client’s primary addiction treatment, compared with 48% of clients.
Conclusions: A large unmet clinical need is evident with a widespread failure to deliver smoking cessation
interventions to an extraordinarily high prevalence population of smokers in addiction services. This is despite the
majority of smokers reporting motivation to quit. Staff smoking and attitudes may be a contributory factor in these
findings.
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Smoking is the largest global cause of preventable death
and disease [1]. Over 10 years ago, UK research highlighted
that smoking prevalence in substance misusers was consid-
erably higher than that in the general population: over
90% of clients in an inpatient drug and alcohol detoxifica-
tion unit [2], and methadone maintenance clinics [3,4]
were recorded as smokers, compared to 27% in the gen-
eral population at that time [5].
Given the adverse consequences of smoking, it is likely
that substance misusers experience a high level of tobacco* Correspondence: ann.mcneill@kcl.ac.uk
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unless otherwise stated.related health problems. Indeed, it has been observed that
people who had received inpatient treatment for alcohol
dependence were more likely to die from a tobacco-
related, rather than alcohol related, cause [6]. Similarly, in
a cohort of over 400 people dependent on narcotics,
smoking was significantly related to the likelihood of dying
over a ten-year period [7]. Furthermore, research has
highlighted a synergistic interaction between alcohol and
smoking for cancer risk [8]. Contrary to the prevailing be-
lief, smoking cessation does not appear to impact nega-
tively on success of abstinence from other substances;
rather a body of evidence suggests continued nicotine de-
pendence may be a risk factor for relapse [9-12], although
the evidence is not always consistent [13].
Evidence from the US from the early 2000s suggests
that substance misusers who smoke are motivated toal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lates to a desire for support and action is not so clear:
whilst three-quarters of a sample of 542 tobacco-using
adults in substance abuse treatment in Colorado were
considering tobacco cessation sometime in the future,
only a third wanted help and even fewer thought smok-
ing cessation should be addressed alongside their sub-
stance abuse treatment [16]. Additionally a recent paper
found that just over half of methadone clients surveyed
in Australia were ‘not seriously thinking about quitting’
[17]. Given substance misusers’ high degree of dependence
[18] and concurrent addiction, it seems likely that this
population would find it hard to stop without support.
US research suggests advice and support are not rou-
tinely available for substance misuse clients undergoing
treatment. A minority (8%) of clients with alcohol de-
pendency reported that alcohol treatment counsellors
encouraged them to ‘quit smoking now’, one third told
them ‘quit in the future’ and a notable 24% told them
‘do not quit’ [15]. American and Australian literature
highlight that this seems to result from the common
misunderstandings that clients do not want to quit
smoking, are unable to quit and quit attempts will have
a negative impact on treatment of other substance use,
as well as a lack of staff knowledge and training [19-22].
Staff attitudes towards smoking cessation programmes
appeared to be influenced by the amount of continuing
education in nicotine addiction received [23] and their
own smoking behaviour [22]. Staff smoking also has the
potential to normalise the behaviour and portray it as a
therapeutic event [24].
Since the millennium, the UK has implemented a num-
ber of tobacco control measures, such as a ban on tobacco
advertising, the implementation of a national network of
NHS Stop Smoking Services and the implementation of a
national smoke-free policy [25,26]. It is therefore import-
ant to assess whether smoking in substance misuse set-
tings has reduced over this period. In addition, recently
published NICE guidance aims to support smoking cessa-
tion, temporary abstinence and smokefree policies in all
secondary healthcare settings including drug and alcohol
services [27], and identifying current smoking behaviour
and attitudes will help to inform policies and practice to
ensure conformity with this guidance in the future.
This study therefore examined the following research
questions:
1. What is the smoking behaviour and motivation to
quit of substance misusers and staff in addiction
services?
2. What smoking cessation support is provided in
addiction services?
3. What are client smokers’ and staff views on the
appropriateness and feasibility of the provision andreceipt of nicotine dependence treatment in the
context of treatment for other addictions?
Methods
Study design
In 2013, short questionnaire surveys for clients and staff
were carried out in a convenience sample from four com-
munity drug treatment services (with substantial opiate
substitution treatment, OST), one inpatient detoxification
unit, and two residential rehabilitation services in, or with
links to, Europe’s largest provider of mental health care,
the South London and Maudsley NHS Foundation Trust.
Each of these services was visited by a researcher for one
day, with the exception of an inpatient detoxification unit
where due to limited numbers of clients on the ward at
any one time, two visits were necessary. The questionnaire
was self-completed or, for clients who had difficulty read-
ing or writing, the questions were read aloud. Question-
naires were anonymous and once completed, sealed in an
envelope and returned.
Participants
All clients and staff present, or visiting, each service on
the day of the survey visit were approached and those
who gave verbal consent were surveyed. No exclusion
criteria were used.
Measures
Staff and client questionnaires were designed to assess
smoking behaviour and attitudes relating to smoking ces-
sation and harm reduction within the context of other
addictions.
For clients, questions collected clinical and demographic
information on age, ethnicity, gender, and main substance
(s) for which they were receiving treatment/support.
Smoking status (‘have you ever smoked’ (yes/no); if yes, ‘in
the past year have you smoked’ (daily/occasionally/never))
was recorded, and Heaviness of Smoking Index (HSI) was
obtained for daily smokers using information on number
of cigarettes smoked per day (CPD) and time to the first
cigarette of the day (TTF) [28]. Motivation to quit was
ascertained using the Motivation To Stop Scale (MTSS,
[29]) and interest in talking to someone about trying to re-
duce the harmfulness of their smoking was recorded.
Those who were interested in receiving advice were fur-
ther asked about interest in different treatment options.
Clients were asked if they had ever received support to
stop smoking by clinicians and whether they had received
support in their current treatment episode. Attitudes to-
wards nicotine dependence treatment were explored, in-
cluding a question relating to when in their primary
addiction treatment smoking should be addressed (op-
tions included early, late or after their primary addiction
treatment), and a question asking them to rate on a 10
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10 = definitely appropriate) how appropriate they thought it
was to treat smoking as an addiction requiring treatment.
For the staff questionnaire, professional status and area
of interest (drugs, alcohol and/or tobacco) were requested.
Respondents were asked how important they would rate
treatment of a number of substances a client may be
using and when in a client’s primary addiction treat-
ment smoking should be addressed (as in client ques-
tionnaire). Staff confidence in supporting clients who
want to give up smoking was assessed on a 10 point scale
ranging from 1 = not at all confident, to 10 = extremely
confident). As in the client questionnaire, smoking behav-
iour, motivation to quit and interest in receiving advice
was determined.
Analysis
Completed questionnaires were coded, entered and ana-
lysed in SPPS version 20 for Windows. Descriptive sta-
tistics were used to obtain medians, interquartile range
and proportions. Chi squared tests were used to deter-
mine relationships between categorical variables and
Wilcoxon Signed Ranks Tests were used to establish sig-
nificant differences between paired ordinal ratings. Due
to small numbers in each of the seven motivational
categories, for statistical analysis, these were collapsed
into three categories: those who wanted to quit immi-
nently (in the next month, three months or soon), those
who wanted to quit but did not know when, and those
that did not want to quit (the ‘I don’t know’ category was
not included in statistical analysis). Current smoking be-
haviour was categorised using frequency of smoking and
HSI into ‘occasional’, ‘daily (low addiction)’, ‘daily (moder-
ate addiction)’ and ‘daily (high addiction)’ smokers. Statis-
tical significance was taken as p < 0.05 for all outcomes.
Ethics statement
This study was deemed by the Research Ethics Team at
the Institute of Psychiatry to be a service evaluation and
approved by the local South London & Maudsley NHS
Foundation Trust Audit Committee in December 2012.
Results
One hundred and sixty three clients and 145 staff com-
pleted the questionnaire, with a response rate of 85%
(191 clients approached) and 97% respectively (150 staff
approached). One hundred and sixteen clients and 101
staff were from 4 NHS community services, 36 clients
and 30 staff were from 2 non-NHS residential services
and 11 clients and 14 staff were from an NHS residential
service. Missing/invalid data on all of the questions was
less than 10% of the total sample (with the exception of
staff motivation to quit, 15% missing data; staff TTF
and HSI, 16%; and clients indicating interest in vareniclineand bupropion; 19% and 17% respectively). Missing/invalid
data were excluded from analysis on an item-by-item basis.
Clients
Clients’ demographic and clinical characteristics are shown
in Table 1(A).
Smoking behaviour and motivation to quit
Ninety four percent (n = 154; 95% CI 90–97) of clients
had smoked at some time in their life and 88% (n = 144;
95% CI 82–92) were currently smoking. Smoking status,
HSI and motivation to quit are shown in Table 2, col-
umn (A). There was a significant relationship between
gender and smoking status (daily, occasional, ex-smoker,
and never) (x2 = 8.9, df = 3, p = 0.030), with a higher pro-
portion of males being daily (88%), occasional (2%) and
ex-smokers (8%), compared to females (84%, 0% and 4%
respectively) and a higher proportion of females never
smokers (12%) compared to males (2%). Smoking preva-
lence was similar across the different substances used
[data not shown]. Seventy five per cent of the daily
smokers were classified as at least moderately addicted
according to the HSI and 79% of clients expressed a de-
sire to quit.
Forty six percent (66) of clients were interested in talk-
ing to someone about trying to reduce the harmfulness
of their smoking behaviour; a further 21% did not know.
Of those interested, the most common request was for
advice on replacing some cigarettes with other forms of
nicotine delivery (87%), but advice on gradual reduction
(77%) and abrupt cessation (53%) were also popular
(Table 3). There was a significant relationship between
clients’ motivational status and interest in advice (x2 =
32.9, df = 4, p < 0.001) with 64% of those who wanted to
quit imminently (in the next month, three months or
soon), 44% of those who wanted to quit but didn’t know
when and only 11% of those who didn’t want to quit, in-
terested in advice.
Treatment provision
Fifty six percent (78) of clients had never received sup-
port to stop smoking by clinicians and only 15% (19)
had received support to stop smoking by clinicians in
their current treatment episode.
Significant differences were found between different set-
tings: residential (24% offered support during current
treatment episode) and community (11% offered support)
settings (x2 = 3.91, df =1, p = 0.048) and between NHS
(11% offered support) and non NHS (31% offered support)
settings, (x2 = 6.80, df = 1, p = 0.009). As all the community
settings were NHS we looked to see if there was a differ-
ence between the one NHS residential and two non-NHS
residential settings; the difference was not significant (9%
and 31% offered support respectively, x2 = 1.97, p = 0.160),
Table 1 Demographic and clinical characteristics of
respondents
(A) Client characteristics % (n)
Sex Total n =156
Female 31 (49)
Male 69 (107)






Ethnicity Total n = 163
White 82 (134)
Non-White 18 (29)





Multiple Substances 31 (51)
Did not specify 10 (16)
(B) Staff characteristics % (n)
Professional Status Total n = 145
Manager 6 (8)
Registered Nurse 17 (25)
Manager and Registered Nurse 2 (3)
Student Nurse 4 (6)
Clinical Psychologist & Consultant Clinical Psychologist 5 (7)
Trainee/Assistant Psychologist 4 (6)
Training & Non-training Grade Doctor 3 (5)
Consultant Psychiatrist/Physician 1 (2)
Healthcare Assistant 6 (8)
Substance misuse worker/practitioner/key worker 17 (25)
Trainee & Qualified Counsellor 6 (9)
Admin and Support 14 (20)
Clinical Other 11 (16)
Non-Clinical Other 3 (5)




Drugs and Alcohol 38 (55)
Tobacco and Alcohol 1 (2)
Tobacco and Drugs 0 (0)
Drugs, Alcohol and Tobacco 21 (31)
None 19 (27)
Table 2 Smoking behaviour and motivation to quit of
clients and staff
(A) Clients % (n) (B) Staff % (n)
Smoking status (Whole sample) Total n = 163 Total n = 144
Never 6 (9) 30 (43)
Ex-smoker 6 (10) 25 (36)
Occasional smoker 1 (2) 19 (27)
Daily smoker 87 (142) 26 (38)
CPD (Daily smokers) Total n = 140 Total n = 38
1-10 cigarettes 32 (45) 55 (21)
11-20 cigarettes 53 (74) 37 (14)
21-30 cigarettes 10 (14) 5 (2)
31+ cigarettes 5 (7) 3 (1)
TTF (Daily smokers) Total n = 130 Total n =32
≤5 minutes 52 (68) 19 (6)
6-30 minutes 34 (44) 22 (7)
31-60 minutes 9 (12) 19 (6)
61+ minutes 5 (6) 41(13)
HSI (Daily smokers) Total n =130 Total n = 32
0-2 (low addiction) 25 (33) 66 (21)
3-4 (moderate addiction) 64 (83) 31 (10)
5-6 (high addiction) 11 (14) 3 (1)
Motivation to quit (All smokers) Total n = 140 Total n = 57
Want to quit imminently (in the
next month, three months or soon)
40 (56) 49 (28)
Want to quit but don’t know when 39 (55) 21 (12)
Do not want to quit 19 (27) 26 (15)
Do not know 1 (2) 4 (2)
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ting was small.Attitudes towards nicotine dependence treatment
Clients rated the appropriateness of treating smoking as
an addiction requiring treatment a median of 10 rated
on a 10-point scale (interquartile range, IQR = 3). Forty
eight percent (64) of clients felt smoking should be
addressed early in their primary addiction treatment,
28% (37) late in their primary addiction treatment and
22% (30) after their primary addiction treatment (2% (3)
ticked multiple time points).Staff
Staffs’ demographic and clinical characteristics are shown
in Table 1(B). A quarter expressed tobacco among their
area of interest and the largest professional categories
(constituting 36% overall) were nurses/nurse managers or
substance misuse workers.
Table 3 Clients’ interest in different smoking cessation and harm reduction advice
If you are interested in receiving advice, what sort of things
would you be interested in hearing about? Advice on -
% Yes (n) % Unsure (n) % No (n) % Don’t know enough (n)
Stopping smoking abruptly (total n = 72) 53 (38) 19 (14) 28 (20)
Stopping smoking by gradually reducing the no. of cigarettes smoked (total n = 73) 77 (56) 5 (4) 18 (13)
Replacing some cigarettes with other forms of nicotine delivery (total n = 76) 87 (66) 5 (4) 8 (6)
NRT to help with withdrawals (total n = 77) 60 (44) 12 (9) 8 (6) 14 (18)
Bupropion (Zyban) to help with withdrawals (total n = 65) 17 (11) 8 (5) 6 (4) 69 (45)
Varenicline (Champix) to help with withdrawals (total n = 63) 17 (11) 6 (4) 6 (4) 70 (44)
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Seventy percent (n = 102; 95% CI 62–77) of staff had
smoked at some point in their life and 45% (n = 65; 95%
CI 37–53) were current smokers with 42% (95% CI 30–
64) of these being occasional smokers. Thirty four per
cent of the daily smokers were classified as being at least
moderately addicted according to the HSI and 70% of
staff expressed a desire to quit (Table 2, column (B)).
Smoking prevalence was similar across the different pro-
fessions although as shown in Table 1(B), numbers in some
categories were very small [data not shown].
Thirty one percent (19) of staff (a further 8% did not
know) were interested in talking to someone about trying
to reduce the harmfulness of their smoking behaviour.
Similar to the clients, there was a significant relationship
between staffs’ motivational status and interest in advice
(x2 = 12.5, df = 4, p 0.014), with 39% of those who wanted
to quit imminently (in the next month, three months or
soon) and 41% of those who wanted to quit but didn’t
know when, interested in advice and 7% of those who
didn’t want to quit interested in advice.
Attitudes towards nicotine dependence treatment
Treatment for smoking was rated by staff as significantly
less important than treatment for other substances a cli-
ent may also be using along side their primary addiction
(Table 4).Table 4 Rating of importance of treating different named sub
If a client was primarily in treatment for x*, on a scale from 1 to 10, ho
that they may also be using:
Primary substance:






Cannabis 7 (5) 7 (4)
Benzos 10 (2) 10 (2)
Smoking 5 (5) 5 (5)
NB There were significant differences between smoking and all other substances
p < 0.001; IQR = inter-quartile range.
*Primary drug treatment.There was no difference in attitudes towards nicotine
dependence treatment according to staff smoking status;
mean (IQR) ratings were: daily smoker 5 (6); occasional
smoker 5.5 (6); ex-smoker 5 (4); never smoker 6 (5).
Twenty nine percent (40) of staff felt smoking should be
addressed early in a client’s primary addiction treatment,
30% (46) late and 33% (46) after (7% ticked multiple time
points). The median rating of staff confidence in support-
ing clients who want to give up smoking was 7 (IQR = 4).
When only including clinical staff (excluding admin and
support), this did not change.
Discussion
Markedly elevated smoking prevalence was observed
amongst substance misusers (88%) and addictions staff
(45%), compared to the general population (19%) [30];
smoking prevalence among clients was similar to that
reported over 10 years ago. Staff and client smokers dis-
played different patterns of smoking with an unusually
high prevalence of occasional smoking being observed
among staff (compared to an occasional smoking preva-
lence of < 3% in the general population at the time [31].
Over three-quarters of clients who smoked expressed a
desire to quit, 22% within the next three months. While
nearly half of the clients who smoked were interested in
talking to someone about reducing the harmfulness of
their smoking behaviour, 56% had never received supportstances
w important would you rate treatment of the following substances
substance:
(total n = 132)
Primary substance:






’ ratings in each primary substance groups; Wilcoxon Signed Ranks Tests,
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support in their current treatment episode. This demon-
strates a clear unmet clinical need which needs to be ur-
gently addressed.
Our study has a number of limitations. We were re-
stricted to using a convenience sample hence our results
derive from participation of the readily available range of
agencies and those present on the days and times of the
visits. Despite this, there is no reason to think that the
extremely high smoking prevalence observed here would
be atypical, especially as smoking prevalence in the gen-
eral population in London is lower than that nationally
[32]. Another limitation is that the accuracy of self-
reported responses given by staff and clients could not
be verified. Additionally, for the small proportion of cli-
ents and staff (15% and 3% respectively) who did not
complete the questionnaire, they may have declined either
because they did not think a questionnaire about smoking
was applicable to them if they did not smoke, or, alterna-
tively, if they did smoke, they may not have wanted to dis-
close information about their behaviour. However our
very high response rates make any such biases unlikely. In
addition, our study has provided an up-to-date snapshot
of smoking and treatment provision in England across a
range of community and residential addiction treatment
settings using standardised questions to enable compari-
sons with general population data.
The elevated prevalence of smoking in substance mis-
users observed in our sample is consistent with surveys
carried out over a decade ago in the UK [2-4]. The lack
of change in smoking prevalence is in contrast with the
falling rates in the general population and needs to be
addressed. It would appear that the implementation of
the comprehensive tobacco control strategy in England is
having little impact on this population of smokers. The
lack of change in smoking behaviour does not reflect a
hardened group of smokers not interested in quitting.
Nearly 80% of client smokers in our sample expressed a
desire to quit compared to 62% in the general population
[29]. Discrepancies between clients’ motivation to quit and
current support provision were apparent, with only a min-
imal proportion of clients receiving support in their
current treatment episode. This is consistent with US lit-
erature showing a motivated client group [14,15] who are
not receiving adequate support for smoking cessation [15].
There was a significant difference in support provision
across treatment settings with residential and non-NHS
settings more likely to offer support; however even in
these ‘optimal’ settings less than a third of clients had been
offered support during their current treatment episode.
Given the distribution of our sample across treatment set-
tings, we were not able to accurately determine whether
the residential versus community or non-NHS versus
NHS factors were the key discriminator for treatmentprovision. Contrary to previous research finding that mo-
tivation to quit did not translate into a desire for advice
and motivated smokers did not think smoking should be
addressed early in treatment [16], in our sample motiv-
ation was associated with a desire for advice, and nearly
half of substance misusers felt that smoking should be
treated early in their primary addiction treatment. This is
in contrast to staff for whom 29% felt that smoking should
be treated early in primary addiction treatment, with over
half (58%) thinking it should be postponed until late in, or
after, their primary addiction treatment. Client acceptabil-
ity of different types of advice and treatment options were
mixed. While advice on how to gradually reduce the num-
ber of cigarettes smoked, and nicotine substitution, were
more popular than advice on abrupt quitting, just over
half were still interested in advice on the latter. Nearly two
thirds of smokers did not know enough about varenicline
or bupropion to indicate an interest, which is of concern
given that they are proven effective treatments.
Given the literature showing staff smoking may influ-
ence their attitudes towards supporting clients to give
up [22], the elevated rates of staff smoking is a concern
both in terms of their own health and the impact it is
having on their clients. Staff smoking has previously
ranged in the literature from 14% to 40% [22], and our
results push the upper boundaries of this, at 45%. This is
over twice as high as the general population prevalence
and well above that recorded in general health profes-
sionals: smoking prevalence in general practitioners was
recorded at only 4% [33]. Additionally, we found that
medical professionals appeared to have a similar preva-
lence of smoking to the other professional groups.
Of interest is the unusual pattern of smoking we ob-
served in staff, with a high proportion of occasional
smokers. It is unclear whether this response is somehow
more socially desirable than reporting daily smoking or
whether such a smoking pattern highlights an attempt to
cut down or quit or is just characteristic of the professional
group. This should be further explored using qualitative
methods. Staff confidence in treating nicotine dependence
varied greatly and there appeared to be no difference
across different staff groups including admin and support
staff. Staff also rated the importance of treating nicotine
dependence significantly lower than other substances.
Recent NICE guidance [27] indicates that support for
smoking cessation and harm reduction needs to be inte-
grated into substance misusers’ standard care; all clients’
smoking status, motivation to quit and desire for advice
should be recorded and acted upon. Additionally, the
range of available behavioural and pharmacological sup-
port options for quitting smoking needs to be made ap-
parent to clients and integrated into a clear clinical
pathway. Staff smoking behaviour needs to be addressed
explicitly, having two-fold beneficial consequences not
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through the provision of better role models and support.
Like clients, a motivation to quit in staff was apparent;
however the relatively low number of staff smokers indicat-
ing a desire to talk to someone about their smoking may
indicate a reluctance to accept help. Training needs are ap-
parent to provide information around the health conse-
quences of smoking including its synergistic effects with
other substances, as well as to increase staffs’ own confi-
dence in supporting clients. Research is needed to establish
whether delivery of interventions to this group produces
standard observed benefits, or whether special, more tai-
lored interventions are required, potentially alongside a
greater understanding of drug use patterns [34]. Addition-
ally staff attitudes and behaviours need re-assessment
following the implementation of a training programme de-
signed to address some of the barriers to and misconcep-
tions about nicotine dependence treatment in substance
misusers. The South London and Maudsley Trust is now
implementing the relevant NICE guidance and introdu-
cing nicotine dependent treatment as part of all its treat-
ment care pathways.
Conclusions
To conclude, a large unmet clinical need is apparent. Smok-
ing prevalence is elevated in both staff and clients in
substance misuse settings. Despite the majority of cli-
ents expressing a desire to quit smoking, there appears to
be a widespread failure to deliver smoking cessation sup-
port and interventions. Staff attitudes regarding nicotine
dependence treatment’s importance, a potential lack of
confidence and their own smoking behaviour may be in-
advertently maintaining this smoking culture.
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